| pubmed-article:15656877 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15656877 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:15656877 | lifeskim:mentions | umls-concept:C0011860 | lld:lifeskim |
| pubmed-article:15656877 | lifeskim:mentions | umls-concept:C0271650 | lld:lifeskim |
| pubmed-article:15656877 | lifeskim:mentions | umls-concept:C0017337 | lld:lifeskim |
| pubmed-article:15656877 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
| pubmed-article:15656877 | lifeskim:mentions | umls-concept:C0596690 | lld:lifeskim |
| pubmed-article:15656877 | lifeskim:mentions | umls-concept:C0033413 | lld:lifeskim |
| pubmed-article:15656877 | lifeskim:mentions | umls-concept:C1706204 | lld:lifeskim |
| pubmed-article:15656877 | lifeskim:mentions | umls-concept:C0439836 | lld:lifeskim |
| pubmed-article:15656877 | lifeskim:mentions | umls-concept:C1555721 | lld:lifeskim |
| pubmed-article:15656877 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:15656877 | pubmed:dateCreated | 2005-1-19 | lld:pubmed |
| pubmed-article:15656877 | pubmed:abstractText | Dyslipidaemia that includes high levels of triglycerides and low high-density lipoprotein cholesterol is a risk factor for type 2 diabetes. Hepatic lipase gene encoding a lipolytic enzyme participating in remodelling of plasma lipoproteins and formation of serum lipid profile is a promising candidate gene for type 2 diabetes. The purpose of the study was to investigate whether the G-250A promoter polymorphism of the LIPC gene predicts the conversion from impaired glucose tolerance (IGT) to type 2 diabetes. | lld:pubmed |
| pubmed-article:15656877 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15656877 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15656877 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15656877 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15656877 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15656877 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15656877 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:15656877 | pubmed:issn | 0954-6820 | lld:pubmed |
| pubmed-article:15656877 | pubmed:author | pubmed-author:LaaksoMM | lld:pubmed |
| pubmed-article:15656877 | pubmed:author | pubmed-author:ChiassonJ-LJL | lld:pubmed |
| pubmed-article:15656877 | pubmed:author | pubmed-author:ZacharovaJJ | lld:pubmed |
| pubmed-article:15656877 | pubmed:author | pubmed-author:STOP-NIDDM... | lld:pubmed |
| pubmed-article:15656877 | pubmed:author | pubmed-author:TodorovaB RBR | lld:pubmed |
| pubmed-article:15656877 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15656877 | pubmed:volume | 257 | lld:pubmed |
| pubmed-article:15656877 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15656877 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15656877 | pubmed:pagination | 185-93 | lld:pubmed |
| pubmed-article:15656877 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:15656877 | pubmed:meshHeading | pubmed-meshheading:15656877... | lld:pubmed |
| pubmed-article:15656877 | pubmed:meshHeading | pubmed-meshheading:15656877... | lld:pubmed |
| pubmed-article:15656877 | pubmed:meshHeading | pubmed-meshheading:15656877... | lld:pubmed |
| pubmed-article:15656877 | pubmed:meshHeading | pubmed-meshheading:15656877... | lld:pubmed |
| pubmed-article:15656877 | pubmed:meshHeading | pubmed-meshheading:15656877... | lld:pubmed |
| pubmed-article:15656877 | pubmed:meshHeading | pubmed-meshheading:15656877... | lld:pubmed |
| pubmed-article:15656877 | pubmed:meshHeading | pubmed-meshheading:15656877... | lld:pubmed |
| pubmed-article:15656877 | pubmed:meshHeading | pubmed-meshheading:15656877... | lld:pubmed |
| pubmed-article:15656877 | pubmed:meshHeading | pubmed-meshheading:15656877... | lld:pubmed |
| pubmed-article:15656877 | pubmed:meshHeading | pubmed-meshheading:15656877... | lld:pubmed |
| pubmed-article:15656877 | pubmed:meshHeading | pubmed-meshheading:15656877... | lld:pubmed |
| pubmed-article:15656877 | pubmed:meshHeading | pubmed-meshheading:15656877... | lld:pubmed |
| pubmed-article:15656877 | pubmed:meshHeading | pubmed-meshheading:15656877... | lld:pubmed |
| pubmed-article:15656877 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15656877 | pubmed:articleTitle | The G-250A substitution in the promoter region of the hepatic lipase gene is associated with the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial. | lld:pubmed |
| pubmed-article:15656877 | pubmed:affiliation | Department of Medicine, University of Kuopio, Kuopio, Finland. | lld:pubmed |
| pubmed-article:15656877 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15656877 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:15656877 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| entrez-gene:3990 | entrezgene:pubmed | pubmed-article:15656877 | lld:entrezgene |
| entrez-gene:24538 | entrezgene:pubmed | pubmed-article:15656877 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:15656877 | lld:entrezgene |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15656877 | lld:pubmed |
